Inbiomotion logo

Inbiomotion

A personalized medicine company focused on the development of biomarkers to predict bone metastasis in cancers

5

Funding Rounds

$7.6m

Money raised

Overview

A personalized medicine company focused on the development of biomarkers to predict bone metastasis in cancers

Funding series

Funding Series Analysis

The company Inbiomotion has raised a total of $2.5m in funding over 5 rounds.

Key Insights:

  • Inbiomotion Series A round: $2.5m
  • Inbiomotion Series B round, March 2016: $2.64m
  • Inbiomotion Series A round, June 2012: $2.4m
  • Inbiomotion Grant (money), March 2016: $60.1k
Inbiomotion logo
Inbiomotion Series A round $2.5m
Inbiomotion logo
Inbiomotion Series B round, March 2016 $2.64m
Inbiomotion logo
Inbiomotion Series A round, June 2012 $2.4m
Inbiomotion logo
Inbiomotion Grant (money), March 2016 $60.1k